Incidence and clinical relevance of ASXL2 mutations in adult AML with t(8;21)(q22;q22): A study of the German-Austrian AML Study Group (AMLSG)

被引：0
|
作者：
Jahn, N. [1 ]
Bullinger, L. [1 ]
Weber, D. [1 ]
Corbacioglu, A. [1 ]
Gaidzik, V [1 ]
Agrawal, M. [1 ]
Schlenk, R. [1 ]
Thal, F. [2 ]
Heuser, M. [2 ]
Krauter, J. [3 ]
Goehring, G. [4 ]
Kuendgen, A. [5 ]
Fiedler, W. [6 ]
Luebbert, M. [7 ]
Ganser, A. [2 ]
Doehner, H. [1 ]
Doehner, K. [8 ]
Paschka, P. [1 ]
机构：
[1] Univ Ulm Klinikum, Innere Med Klin 3, Ulm, Germany
[2] Hannover Med Sch, Klin Hamatol Hamostaseol Onkol & Stammzelltranspl, D-30623 Hannover, Germany
[3] Klinikum Braunschweig, Med Klin 3, Braunschweig, Germany
[4] Hannover Med Sch, Inst Humangenet, D-30623 Hannover, Germany
[5] Univ Klinikum, Klin Hamatol Onkol & Klin Immunol, Dusseldorf, Germany
[6] Univ Klinikum Hamburg Eppendorf, Med Klin & Poliklin 2, Hamburg, Germany
[7] Univ Freiburg Klinikum, Klin Innere Med 1, Freiburg, Germany
[8] Univ Ulm Klinikum, Klin Innere Med 3, Ulm, Germany
来源：
Oncology Research and Treatment | 2015年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V538
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [41] Prognostic Factors of Pediatric Acute Myeloid Leukemia Patients with t(8;21) (q22;q22): A Single-Center Retrospective Study
    Yang, Jiapeng
    Zhu, Xiaohua
    Zhang, Honghong
    Fu, Yang
    Li, Zifeng
    Xing, Ziping
    Yu, Yi
    Cao, Ping
    Le, Jun
    Jiang, Junye
    Li, Jun
    Wang, Hongsheng
    Zhai, Xiaowen
    CHILDREN-BASEL, 2024, 11 (05):
  • [42] Complex t(2;21;8)(p12;q22;q22): a variant t(8;21) in a patient with acute myeloid leukemia (AML-M2). (Retraction of vol 188, pg 95, 2009)
    Wang, H.
    Yang, W.
    Shao, H.
    Zhang, J.
    Li, Q.
    Liao, A.
    Li, Y.
    Liu, Z.
    CANCER GENETICS AND CYTOGENETICS, 2009, 192 (01) : 54 - 54
  • [43] Variant translocation t(2;21;8)(q36;q22;q22) with RUNX1/CBFA2T1 (AML1/ETO) transcript in a case of acute myelogenous leukemia
    Hsiao, HH
    Sashida, G
    Kodama, A
    Fukutake, K
    Ohyashiki, K
    CANCER GENETICS AND CYTOGENETICS, 2005, 159 (01) : 96 - 97
  • [44] Adult acute myeloid leukemia (AML) patients (PTS) with t(8;21)(q22;q22) have a superior outcome when repetitive cycles of high-dose cytarabine (HDAC) are administered.
    Byrd, JC
    Dodge, R
    Carroll, A
    Baer, MR
    Edwards, C
    Stamberg, J
    Qumsiyeh, M
    Moore, JO
    Mayer, RJ
    Schiffer, CA
    Bloomfield, CD
    BLOOD, 1998, 92 (10) : 312A - 313A
  • [45] Mutations in the receptor tyrosin kinase and Ras pathway in patients with acute myeloblastic leukemia carrying t(8;21)(q22;q22) or inv(16)(p13q22)
    Nanri, T
    Matsuno, N
    Kawakita, T
    Suzushima, H
    Kawano, F
    Mitsuya, H
    Asou, N
    BLOOD, 2003, 102 (11) : 865A - 866A
  • [46] Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22; q22.1) acute myeloid leukemia (AML)
    Agrawal, Mridul
    Schwarz, Peggy
    Giaimo, Benedetto Daniele
    Bedzhov, Ivan
    Corbacioglu, Andrea
    Weber, Daniela
    Gaidzik, Verena I.
    Jahn, Nikolaus
    Ruecker, Frank G.
    Schroeder, Thomas
    Kindler, Thomas
    Wattad, Mohammed
    Goetze, Katharina
    Luebbert, Michael
    Salwender, Hans
    Ringhoffer, Mark
    Lange, Elisabeth
    Koller, Elisabeth
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Bullinger, Lars
    Paschka, Peter
    Doehner, Hartmut
    Geiger, Hartmut
    Borggrefe, Tilman
    Doehner, Konstanze
    Oswald, Franz
    LEUKEMIA, 2020, 34 (02) : 630 - 634
  • [47] Functional and clinical characterization of the alternatively spliced isoform AML1-ETO9a in adult patients with translocation t(8;21)(q22;q22.1) acute myeloid leukemia (AML)
    Mridul Agrawal
    Peggy Schwarz
    Benedetto Daniele Giaimo
    Ivan Bedzhov
    Andrea Corbacioglu
    Daniela Weber
    Verena I. Gaidzik
    Nikolaus Jahn
    Frank G. Rücker
    Thomas Schroeder
    Thomas Kindler
    Mohammed Wattad
    Katharina Götze
    Michael Lübbert
    Hans Salwender
    Mark Ringhoffer
    Elisabeth Lange
    Elisabeth Koller
    Felicitas Thol
    Michael Heuser
    Arnold Ganser
    Lars Bullinger
    Peter Paschka
    Hartmut Döhner
    Hartmut Geiger
    Tilman Borggrefe
    Konstanze Döhner
    Franz Oswald
    Leukemia, 2020, 34 : 630 - 634
  • [48] Measurable Residual Disease (MRD) Monitoring in Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1) RUNX1-RUNX1T1 Identifies Patients at High Risk of Relapse: Results of the AML Study Group (AMLSG)
    Ruecker, Frank G.
    Agrawal, Mridul
    Corbacioglu, Andrea
    Weber, Daniela
    Kapp-Schwoerer, Silke
    Gaidzik, Verena I.
    Jahn, Nikolaus
    Schroeder, Thomas
    Wattad, Mohammad
    Luebbert, Michael
    Koller, Elisabeth
    Kindler, Thomas
    Goetze, Katharina
    Ringhoffer, Mark
    Westermann, Jorg
    Fiedler, Walter
    Horst, Heinz A.
    Greil, Richard
    Schroers, Roland
    Mayer, Karin
    Heinicke, Thomas
    Krauter, Jurgen
    Schlenk, Richard F.
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Bullinger, Lars
    Paschka, Peter
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2019, 134
  • [49] Development of AML with t(8;21)(q22;q22) and RUNX1-RUNX1T1 fusion following Philadelphia-negative clonal evolution during treatment of CML with Imatinib
    Schafhausen, Philippe
    Dierlamm, Judith
    Bokemeyer, Carsten
    Bruemmendorf, Tim H.
    Bacher, Ulrike
    Zander, Axel R.
    Schnittger, Susanne
    Hochhaus, Andreas
    CANCER GENETICS AND CYTOGENETICS, 2009, 189 (01) : 63 - 67
  • [50] t(8;21)(q22;q22) fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression
    Okumura, Akiko J.
    Peterson, Luke F.
    Okumura, Fumihiko
    Boyapati, Anita
    Zhang, Dong-Er
    BLOOD, 2008, 112 (04) : 1392 - 1401
12345